Cargando…
Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups
INTRODUCTION: Glioblastoma with oligodendroglioma component (GBM-O) was recognized as a histologic pattern of glioblastoma (GBM) by the World Health Organization (WHO) in 2007 and is distinguished by the presence of oligodendroglioma-like differentiation. To better understand the genetic underpinnin...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711079/ https://www.ncbi.nlm.nih.gov/pubmed/26757882 http://dx.doi.org/10.1186/s40478-015-0270-7 |
_version_ | 1782409914836058112 |
---|---|
author | Hinrichs, Benjamin H. Newman, Scott Appin, Christina L. Dunn, William Cooper, Lee Pauly, Rini Kowalski, Jeanne Rossi, Michael R. Brat, Daniel J. |
author_facet | Hinrichs, Benjamin H. Newman, Scott Appin, Christina L. Dunn, William Cooper, Lee Pauly, Rini Kowalski, Jeanne Rossi, Michael R. Brat, Daniel J. |
author_sort | Hinrichs, Benjamin H. |
collection | PubMed |
description | INTRODUCTION: Glioblastoma with oligodendroglioma component (GBM-O) was recognized as a histologic pattern of glioblastoma (GBM) by the World Health Organization (WHO) in 2007 and is distinguished by the presence of oligodendroglioma-like differentiation. To better understand the genetic underpinnings of this morphologic entity, we performed a genome-wide, integrated copy number, mutational and transcriptomic analysis of eight (seven primary, primary secondary) cases. RESULTS: Three GBM-O samples had IDH1 (p.R132H) mutations; two of these also demonstrated 1p/19q co-deletion and had a proneural transcriptional profile, a molecular signature characteristic of oligodendroglioma. The additional IDH1 mutant tumor lacked 1p/19q co-deletion, harbored a TP53 mutation, and overall, demonstrated features most consistent with IDH mutant (secondary) GBM. Finally, five tumors were IDH wild-type (IDHwt) and had chromosome seven gains, chromosome 10 losses, and homozygous 9p deletions (CDKN2A), alterations typical of IDHwt (primary) GBM. IDHwt GBM-Os also demonstrated EGFR and PDGFRA amplifications, which correlated with classical and proneural expression subtypes, respectively. CONCLUSIONS: Our findings demonstrate that GBM-O is composed of three discrete molecular subgroups with characteristic mutations, copy number alterations and gene expression patterns. Despite displaying areas that morphologically resemble oligodendroglioma, the current results indicate that morphologically defined GBM-O does not correspond to a particular genetic signature, but rather represents a collection of genetically dissimilar entities. Ancillary testing, especially for IDH and 1p/19q, should be used for determining these molecular subtypes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-015-0270-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4711079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47110792016-01-14 Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups Hinrichs, Benjamin H. Newman, Scott Appin, Christina L. Dunn, William Cooper, Lee Pauly, Rini Kowalski, Jeanne Rossi, Michael R. Brat, Daniel J. Acta Neuropathol Commun Research INTRODUCTION: Glioblastoma with oligodendroglioma component (GBM-O) was recognized as a histologic pattern of glioblastoma (GBM) by the World Health Organization (WHO) in 2007 and is distinguished by the presence of oligodendroglioma-like differentiation. To better understand the genetic underpinnings of this morphologic entity, we performed a genome-wide, integrated copy number, mutational and transcriptomic analysis of eight (seven primary, primary secondary) cases. RESULTS: Three GBM-O samples had IDH1 (p.R132H) mutations; two of these also demonstrated 1p/19q co-deletion and had a proneural transcriptional profile, a molecular signature characteristic of oligodendroglioma. The additional IDH1 mutant tumor lacked 1p/19q co-deletion, harbored a TP53 mutation, and overall, demonstrated features most consistent with IDH mutant (secondary) GBM. Finally, five tumors were IDH wild-type (IDHwt) and had chromosome seven gains, chromosome 10 losses, and homozygous 9p deletions (CDKN2A), alterations typical of IDHwt (primary) GBM. IDHwt GBM-Os also demonstrated EGFR and PDGFRA amplifications, which correlated with classical and proneural expression subtypes, respectively. CONCLUSIONS: Our findings demonstrate that GBM-O is composed of three discrete molecular subgroups with characteristic mutations, copy number alterations and gene expression patterns. Despite displaying areas that morphologically resemble oligodendroglioma, the current results indicate that morphologically defined GBM-O does not correspond to a particular genetic signature, but rather represents a collection of genetically dissimilar entities. Ancillary testing, especially for IDH and 1p/19q, should be used for determining these molecular subtypes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-015-0270-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-01-13 /pmc/articles/PMC4711079/ /pubmed/26757882 http://dx.doi.org/10.1186/s40478-015-0270-7 Text en © Hinrichs et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Hinrichs, Benjamin H. Newman, Scott Appin, Christina L. Dunn, William Cooper, Lee Pauly, Rini Kowalski, Jeanne Rossi, Michael R. Brat, Daniel J. Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups |
title | Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups |
title_full | Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups |
title_fullStr | Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups |
title_full_unstemmed | Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups |
title_short | Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups |
title_sort | farewell to gbm-o: genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711079/ https://www.ncbi.nlm.nih.gov/pubmed/26757882 http://dx.doi.org/10.1186/s40478-015-0270-7 |
work_keys_str_mv | AT hinrichsbenjaminh farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups AT newmanscott farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups AT appinchristinal farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups AT dunnwilliam farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups AT cooperlee farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups AT paulyrini farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups AT kowalskijeanne farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups AT rossimichaelr farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups AT bratdanielj farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups |